4-O-Methylascochlorin inhibits the prolyl hydroxylation of hypoxia-inducible factor-1α, which is attenuated by ascorbate.

The Journal of Antibiotics
Tetsuya KondoTakao Kataoka

Abstract

4-O-Methylascochlorin (MAC), a methylated derivative of ascochlorin, was previously shown to promote the accumulation of hypoxia-inducible factor (HIF)-1α in human breast adenocarcinoma MCF-7 cells. In the present study, we further investigated the effects of MAC on the expression and function of HIF-1α in human fibrosarcoma HT-1080 cells. MAC promoted the accumulation of the HIF-1α protein without affecting its constitutive mRNA expression and augmented the transcriptional activation of HIF target genes. Ascorbate, but not N-acetylcysteine, attenuated MAC-mediated HIF-1α accumulation. MAC-induced increases in HIF-1α transcriptional activity were also attenuated by ascorbate. MAC inhibited the hydroxylation of HIF-1α at the proline 564 residue, while it was reversed by ascorbate. MAC slightly decreased the intracellular concentration of ascorbate. The present results demonstrated that MAC promoted the accumulation of HIF-1α by preventing prolyl hydroxylation, and ascorbate attenuated the MAC-mediated inhibition of HIF-1α prolyl hydroxylation.

References

Nov 1, 1973·The Journal of Antibiotics·M SawadaK Ando
Oct 1, 1969·The Journal of Antibiotics·Y NawataY Iitaka
Jun 12, 2004·Apoptosis : an International Journal on Programmed Cell Death·M TsurugaJ Magae
Jul 24, 2004·The Journal of Biological Chemistry·Konstantin SalnikowKazimierz S Kasprzak
Jan 25, 2005·Cardiovascular Research·Gilles Pagès, Jacques Pouysségur
Mar 30, 2007·The Journal of Antibiotics·Mie TsurugaJunji Magae
Apr 18, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David L GillespieRandy L Jensen
Feb 9, 2008·Cell Death and Differentiation·A Weidemann, R S Johnson
May 24, 2008·Molecular Cell·William G Kaelin, Peter J Ratcliffe
May 27, 2008·Journal of the International Society of Sports Nutrition·Chad Kerksick, Darryn Willoughby
Nov 7, 2008·Nature Reviews. Cancer·Jessica A BertoutM Celeste Simon
Jan 24, 2009·Nature Reviews. Drug Discovery·Peter FraislPeter Carmeliet
Mar 24, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Yinghui ZhangXiang-Dong Wang
Apr 7, 2010·Nature Reviews. Gastroenterology & Hepatology·Sean P Colgan, Cormac T Taylor
Oct 23, 2010·Molecular Cell·Amar J MajmundarM Celeste Simon
Oct 23, 2010·Molecular Cell·Shomit SenguptaDavid M Sabatini
Feb 19, 2011·Biochemical and Biophysical Research Communications·Ji-Hak JeongYoung-Chae Chang
Mar 17, 2011·Expert Opinion on Investigational Drugs·Eugene Muchnik, Joshua Kaplan
Dec 4, 2012·Trends in Biochemical Sciences·Brian W WongPeter Carmeliet
Nov 5, 2014·Immunity·Asis PalazonRandall S Johnson
Jul 25, 2015·Journal of Cellular Biochemistry·Shuyang Chen, Nianli Sang
Aug 19, 2015·Seminars in Cell & Developmental Biology·Bo Qiu, M Celeste Simon
Nov 13, 2015·European Journal of Immunology·Wenkai RenYulong Yin
Dec 15, 2015·Nature Reviews. Nephrology·Patrick H Maxwell, Kai-Uwe Eckardt
Feb 29, 2016·Apoptosis : an International Journal on Programmed Cell Death·Jae-Moon ShinYoung-Chae Chang
Mar 31, 2016·Nature Cell Biology·Edward L LaGory, Amato J Giaccia
Jan 1, 2018·Biochimie·Andrey I OsipyantsVladimir I Tishkov
Feb 1, 2018·International Journal of Molecular Sciences·Joshua M KaplanSean Dikdan

❮ Previous
Next ❯

Methods Mentioned

BETA
Transfection
PCR
Assay
ubiquitination

Software Mentioned

Image

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.